Non-valvular Atrial Fibrillation (AFib) increases the risk of stroke 5 times over that of patients who have normal sinus rhythm. Selecting the antithrombotic that best fits each patient is essential in reducing their risk of stroke.
PS is a 64-year-old woman with newly diagnosed non-valvular atrial fibrillation (AFib) and a history of hypertension and diabetes. Her current blood pressure is 155/94 mm Hg on antihypertensive therapy. She has no history of heart failure or prior stroke, and her renal function is normal.
Please select one answer and click the Next button below.
Supported by Bristol-Myers Squibb
© Copyright 2021, American Pharmacists Association All Rights Reserved.